top of page

Scientific
Publications

At BioMarket Solution, we value scientific excellence and evidence-driven impact. Our founder, Tavneet Singh, Ph.D., M.S., has contributed to multiple peer-reviewed manuscripts and scientific conference presentations in collaboration with leading researchers and healthcare organizations.

Peer-Reviewed Manuscripts

  • Choi BM, Singh T, Nili M, Lam C, et al. Understanding the Characteristics and Burden of Cognitive Impairments in Schizophrenia in the US: Medical Expenditure Panel Survey. J Clin Psychiatry. 2025;86(3):25m15794 https://doi.org/10.4088/JCP.25m15794 

​

  • Singh T, Lebouille-Veldman AB, Patel Y, et al. The Impact of Tort Reforms on the Neurosurgical Malpractice Environment: A Systematic Review of Literature. World Neurosurg. 2023;173:218-225.e4. https://doi.org/10.1016/j.wneu.2023.02.072

​​

  • Ehsan AN, Wu CA, Minasian A, Singh T, et al. Financial Toxicity Among Patients With Breast Cancer Worldwide: A Systematic Review and Meta-analysis. JAMA Netw Open. 2023;6(2):e2255388. https://doi.org/10.1001/jamanetworkopen.2022.55388
    (Featured in Forbes and 30+ other news outlets)

Conference Abstracts & Presentations

  • Singh T, Choi BM, Nili M, et al. Humanistic Burden of Cognitive Symptoms Among Patients with Schizophrenia Using the United States Medical Expenditure Panel Survey Data. Schizophrenia International Research Society Congress, 2024.

​​

  • Choi BM, Singh T, Nili M, et al. Economic Burden of Cognitive Impairment Among Patients with Schizophrenia Using United States Medical Expenditure Panel Survey Data. Journal of Managed Care & Specialty Pharmacy, Vol 30, 2024.

​

  • Saunders AC, Singh T, Lee A, et al. Health Care Resource Utilization (HCRU) and Cost of Management of Cytokine Release Syndrome and Neurological Events in Patients with R/R Follicular Lymphoma Receiving Lisocabtagene Maraleucel in the TRANSCEND FL Study. Blood. 2023;142(Suppl 1):7257-7257.

​​

  • Saunders AC, Singh T, Lee A, et al. Estimation of Postinfusion Resource Use and Total Costs of Care for Patients with R/R Follicular Lymphoma Receiving Lisocabtagene Maraleucel in the TRANSCEND FL Study. Blood. 2023;142(Suppl 1):5084-5084.

​

  • Singh T, Yunusa I, Bhatt S, Murimi-Worstell IB. Incidence and Risk Factors of Newly Diagnosed Atrial Fibrillation in Colorectal Cancer Patients. Value in Health. 2023;26:S36.

​

  • Singh T, Nawabi NLA, Lassarén P, et al. States with Tort Reforms: A Systematic Review to Evaluate the Impact on Claims Frequency, Imaging Rates, Physician Supply and Malpractice Insurance Premiums. Value in Health. 2022.

All publications listed were authored by Dr. Singh during his tenure in previous roles across academia and industry, including BluePath Solutions,  and MCPHS University.

bottom of page